Filtered By:
Management: Partnerships
This page shows you your search results in order of date.
Order by Relevance | Date
Total 205 results found since Jan 2013.
AI Cough-Monitoring Can Change the Way We Diagnose Disease
How many times do you cough a day? Do you cough more when you’re indoors or outside? Or more often after you eat? Or at night?
Chances are, your cough memory might not be that accurate. But all of that information about your coughing patterns could be an untapped resource to better understand your health. Coughs may be benign ways to clear a little extra phlegm, or they could be early signs of more serious conditions such as asthma, GERD (gastroesophageal reflux disease), or even lung cancer.
“In the era of precision health, it’s ironic that such a problematic symptom is simply unmeasured,” says Pet...
Source: TIME: Health - April 3, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Technology Source Type: news
Challenges in the Management of Asthma in Older Adults
AbstractPurpose of reviewAsthma is a heterogeneous and variable disease directly influenced by genetic factors, environmental triggers, and lung development throughout life. Elderly with asthma have unique needs not fully addressed by current guidelines. This present review aims to discuss the particularities of asthma in older adults and present an overview of tailored treatment strategies in the geriatric population.Recent findingsThe physiologic aging process promotes biological changes leading to dilatation of air spaces, deterioration of lung function, and dysregulation of the immune system. In advanced age, asthma ma...
Source: Current Treatment Options in Allergy - February 21, 2023 Category: Allergy & Immunology Source Type: research
Janssen and Global Partners to Discontinue Phase 3 Mosaico HIV Vaccine Clinical Trial
LEIDEN, THE NETHERLANDS, (January 18, 2023) – The Janssen Pharmaceutical Companies of Johnson & Johnson, together with a consortium of global partners, today announced the results of an independent, scheduled data review of the Phase 3 Mosaico study (also known as HPX3002/HVTN706) of Janssen’s investigational HIV vaccine regimen. The study’s independent Data and Safety Monitoring Board (DSMB) determined that the regimen was not effective in preventing HIV infection compared to placebo among study participants. No safety issues with the vaccine regimen were identified.In light of the DSMB’s determination, the Mo...
Source: Johnson and Johnson - January 18, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Why the U.S. Doesn ’t Have a Nasal Vaccine for COVID-19
The U.S. led the world in quickly developing COVID-19 vaccines—one of the few bright spots in the country’s otherwise criticized response. But while injectable vaccines are effective in protecting people from getting sick with COVID-19, they are less able to block infection. In order to put the pandemic behind us, the world will need a way to stop infections and spread of the virus. That’s where a different type of vaccine, one that works at the places where the virus gets into the body, will likely prove useful.
Here, though, the U.S. is losing its edge. In September, India approved a nasal COVID-19 vacc...
Source: TIME: Health - October 31, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Episode 4: Team Effort: Multidisciplinary Approach to Severe Asthma Episode 4: Team Effort: Multidisciplinary Approach to Severe Asthma
Drs Wechsler and Jackson discuss their partnerships with nurses, asthma educators, psychologists, speech therapists, and other specialists when diagnosing and treating patients with severe asthma.Medscape
Source: Medscape Allergy Headlines - October 4, 2022 Category: Allergy & Immunology Tags: Pulmonary Medicine InDiscussion Source Type: news
New head of U.S. aid program for HIV/AIDS vows to refocus attention on the other, ‘silent’ pandemic
On 13 June, John Nkengasong, 58, was appointed the first African-born head of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), a program that helps more than 50 countries respond to their HIV/AIDS epidemics. Nkengasong, who grew up in Cameroon and became a U.S. citizen in 2007, previously ran the Africa Centres for Disease Control and Prevention (Africa CDC).
PEPFAR is credited with helping save more than 20 million lives since its inception in 2003. It had a $10.7 billion budget in 2021, more than half of it spent on HIV treatment and care. The agency has relied on an acting director since Deborah Birx...
Source: Science of Aging Knowledge Environment - July 5, 2022 Category: Geriatrics Source Type: research
---
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, was interviewed by "Family Guy" creator Seth MacFarlane about lessons the nation learned from the pandemic, and a few other non-serious questions. They appeared at the 2022 Life Itself conference, a health and wellness event presented in partnership with CNN.
Source: CNN.com - Health - June 2, 2022 Category: Consumer Health News Source Type: news
HIV/AIDS Community Information Outreach Program (ACIOP): A Landmark NIH Conference and an Enduring NLM Role in Meeting the Affected Community's Need for Information Access
Stud Health Technol Inform. 2022 Feb 1;288:263-272. doi: 10.3233/SHTI211002.ABSTRACTIn June 1993, the National Library of Medicine (NLM) joined with the National Institutes of Health's (NIH) Office of AIDS Research (OAR), and the National Institute of Allergy and Infectious Diseases (NIAID) to host a conference at a pivotal time in the HIV/AIDS epidemic to understand better the information needs of five major constituency groups: clinical researchers; clinical providers; news media and the public; patients; and the affected community. NLM's director, Donald A.B. Lindberg M.D., and staff sought to identify new program possi...
Source: Studies in Health Technology and Informatics - February 1, 2022 Category: Information Technology Authors: Gale A Dutcher Source Type: research
